Professional Summary
Professional Overview
Georg Buchner is an experienced business executive with a strong background in the pharmaceutical and biotechnology industries. As the Group Chief Business Officer at Helsinn Group, he is responsible for overseeing the company's business development, licensing, and commercial operations across global markets.
Experience Summary
Current Role
As the Group Chief Business Officer at Helsinn Group, Georg Buchner is responsible for leading the company's business development, licensing, and commercial operations. He plays a pivotal role in identifying and securing strategic partnerships, in-licensing opportunities, and new product acquisitions to drive Helsinn's growth and market expansion. Under his leadership, the company has successfully executed several high-profile deals and expanded its global footprint.
Career Progression
Prior to his current role, Georg held various senior-level positions in the industry, including Group Head of Business Development and Head of Licensing and Business Development (Commercial Operations) at Helsinn Group. He has also served as an Interim Chief Business Officer at Elasmogen Ltd and held leadership roles at Shield Therapeutics plc, Amgen, and Silence Therapeutics, among others. Throughout his career, Georg has demonstrated a strong track record of driving business growth, forging strategic alliances, and navigating complex licensing and M&A transactions.
Academic Background
Georg holds a PhD from King's College London and an MBA from the Judge Institute/Cambridge. His academic background, combined with his extensive industry experience, has equipped him with a unique blend of technical expertise and business acumen.
Areas of Expertise
Georg's areas of expertise include:
- Business development and licensing
- Commercial operations and strategy
- Strategic partnerships and alliance management
- Mergers and acquisitions
- Pharmaceutical and biotechnology industry knowledge
Professional Impact
During his tenure, Georg has played a pivotal role in shaping Helsinn's business strategy and securing several high-profile deals that have contributed to the company's growth and market position. He is recognized as a respected industry leader and has actively contributed to various industry initiatives and organizations.
Conclusion
With his extensive experience, strong business acumen, and proven track record of success, Georg Buchner is well-positioned to continue driving Helsinn Group's strategic initiatives and contributing to the company's long-term growth and success in the pharmaceutical and biotechnology sectors.
